Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis

  • No Comments

Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis

Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis 1811 2560 Metabolism & Cancer
Leave a Reply
Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape
Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable for MCT4 inhibition
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here